Skip to main content
. 2015 Jun;12(2):117–125. doi: 10.7497/j.issn.2095-3941.2015.0012

Figure 3.

Figure 3

Kaplan-Meier curves for PFS of 52 patients with stages III-IV CSCLC. The median PFS of the two groups nearly reached a significant difference (19.5 vs. 7.6 months, P=0.071). PFS, progression-free survival; CSCLC, combined small-cell lung cancer.